Literature DB >> 20948261

[Syndrome of inappropriate antidiuretic hormone secretion following adjuvant CDDP and 5-FU administration in a patient with esophageal carcinoma].

Takuya Horio1, Hironori Tsujimoto, Takayoshi Akase, Naoko Sakamoto, Yoshihisa Yaguchi, Shuuichi Hiraki, Satoshi Aiko, Hanako Takechi, Kazuo Hase, Tadaaki Maehara.   

Abstract

A case of hyponatremia following the first course of systemic adjuvant chemotherapy with cisplatin (CDDP) and 5-FU in a previously treated patient with esophageal cancer is reported. A 61-year-old man was admitted to our hospital for adjuvant chemotherapy after transthoracic esophagectomy and 3-field lymphadenectomy for esophageal cancer. Six days following chemotherapy, his serum sodium concentration was found to be 118 mEq/L, without edema or dehydration. This hyponatremic state was diagnosed as the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) induced by CDDP, based on the hypo-osmolality of his serum and urine, and an inappropriate level of plasma vasopressin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20948261

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

1.  Syndrome of inappropriate antidiuretic hormone secretion as a side effect of chemotherapy for testicular cancer: A case report.

Authors:  Koki Maeda; Susumu Kageyama; Takashi Osafune; Yoshikata Masuda; Shota Nakagawa; Kenji Miki; Shun Esumi; Maiko Kakita-Kobayashi; Tetsuya Yoshida; Mitsuhiro Narita; Akihiro Kawauchi
Journal:  IJU Case Rep       Date:  2019-10-11

Review 2.  Concurrent chemo-radiotherapy with S-1 as an alternative therapy for elderly Chinese patients with non-metastatic esophageal squamous cancer: evidence based on a systematic review and meta-analysis.

Authors:  Guo-Min Song; Xu Tian; Xiao-Ling Liu; Hui Chen; Jian-Guo Zhou; Wei Bian; Wei-Qing Chen
Journal:  Oncotarget       Date:  2017-06-06

3.  Preoperative Serum Sodium Level as a Prognostic and Predictive Biomarker for Adjuvant Therapy in Esophageal Cancer.

Authors:  Qifeng Wang; Lin Peng; Yongtao Han; Tao Li; Wei Dai; Yi Wang; Lei Wu; Yang Wei; Tianpeng Xie; Qiang Fang; Qiang Li; Jinyi Lang; Bangrong Cao
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.